Jennison Associates’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-1,644,155
| Closed | -$71M | – | 764 |
|
|
2015
Q3 | $71M | Buy |
1,644,155
+59,956
| +4% | +$2.59M | 0.07% | 237 |
|
|
2015
Q2 | $66.9M | Buy |
1,584,199
+12,832
| +0.8% | +$542K | 0.06% | 282 |
|
|
2015
Q1 | $60.9M | Buy |
1,571,367
+661,894
| +73% | +$25.7M | 0.06% | 297 |
|
|
2014
Q4 | $30.6M | Sell |
909,473
-17,966
| -2% | -$605K | 0.03% | 398 |
|
|
2014
Q3 | $32.5M | Buy |
927,439
+5,239
| +0.6% | +$183K | 0.03% | 390 |
|
|
2014
Q2 | $30.3M | Buy |
922,200
+135,098
| +17% | +$4.44M | 0.03% | 393 |
|
|
2014
Q1 | $29M | Buy |
787,102
+4,159
| +0.5% | +$153K | 0.03% | 404 |
|
|
2013
Q4 | $30M | Buy |
782,943
+8,380
| +1% | +$322K | 0.03% | 400 |
|
|
2013
Q3 | $21.2M | Buy |
774,563
+7,264
| +0.9% | +$199K | 0.02% | 426 |
|
|
2013
Q2 | $16.1M | Buy |
+767,299
| New | +$16.1M | 0.02% | 450 |
|